BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30060818)

  • 21. Ceramide-induced cell death in malignant cells.
    Carpinteiro A; Dumitru C; Schenck M; Gulbins E
    Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
    J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells.
    Castillo SS; Levy M; Thaikoottathil JV; Goldkorn T
    Exp Cell Res; 2007 Jul; 313(12):2680-6. PubMed ID: 17498692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
    Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
    Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in sphingomyelinases, ceramide, Bax, Bcl(2), and caspase-3 during and after experimental status epilepticus.
    Mikati MA; Zeinieh M; Habib RA; El Hokayem J; Rahmeh A; El Sabban M; Usta J; Dbaibo G
    Epilepsy Res; 2008 Oct; 81(2-3):161-6. PubMed ID: 18603412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingomyelinases and Liver Diseases.
    Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceramide and sphingomyelinases in the regulation of stress responses.
    Sawai H; Hannun YA
    Chem Phys Lipids; 1999 Nov; 102(1-2):141-7. PubMed ID: 11001568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An acidic sphingomyelinase Type C activity from Mycobacterium tuberculosis.
    Castro-Garza J; González-Salazar F; Quinn FD; Karls RK; De La Garza-Salinas LH; Guzmán-de la Garza FJ; Vargas-Villarreal J
    Rev Argent Microbiol; 2016; 48(1):21-6. PubMed ID: 26948102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretory sphingomyelinase.
    Tabas I
    Chem Phys Lipids; 1999 Nov; 102(1-2):123-30. PubMed ID: 11001566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the ceramide level, a novel therapeutic concept?
    Claus R; Russwurm S; Meisner M; Kinscherf R; Deigner HP
    Curr Drug Targets; 2000 Sep; 1(2):185-205. PubMed ID: 11465070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
    Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
    Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
    Claus RA; Dorer MJ; Bunck AC; Deigner HP
    Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
    Matmati N; Hannun YA
    J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of interleukin-1beta-activated neutral sphingomyelinase by protein kinase C in rat mesangial cells.
    Kaszkin M; Huwiler A; Scholz K; van den Bosch H; Pfeilschifter J
    FEBS Lett; 1998 Nov; 440(1-2):163-6. PubMed ID: 9862447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
    Marchesini N; Osta W; Bielawski J; Luberto C; Obeid LM; Hannun YA
    J Biol Chem; 2004 Jun; 279(24):25101-11. PubMed ID: 15051724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2).
    Yi J; Qi B; Yin J; Li R; Chen X; Hu J; Li G; Zhang S; Zhang Y; Yang M
    Nat Commun; 2023 Nov; 14(1):7755. PubMed ID: 38012235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
    Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
    Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the ceramide signaling pathway in modulating the differentiated state of porcine thyroid cells.
    Schneider C; Delorme N; Buisson-Legendre N; Bellon G; Emonard H; Btaouri HE; Hornebeck W; Haye B; Martiny L
    Lipids; 2000 Nov; 35(11):1259-68. PubMed ID: 11132185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin.
    Mansat V; Bettaïeb A; Levade T; Laurent G; Jaffrézou JP
    FASEB J; 1997 Jul; 11(8):695-702. PubMed ID: 9240970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid and neutral sphingomyelinases: roles and mechanisms of regulation.
    Marchesini N; Hannun YA
    Biochem Cell Biol; 2004 Feb; 82(1):27-44. PubMed ID: 15052326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.